Official announcements
Search narrowed by
Replacement
|
Medicines
|
18/11/2010
The marketing authorization holder has informed its supplied customers by letter dated 18.11.2010 that due to 5 complaints about visible particles after reconstitution of the product, which occurred in two batches of this medicinal speciality, the…
Recall
|
Medicines
|
17/11/2010
Ebewe/Sandox has initiated a voluntary recall of certain lots of ebetraxate as a precautionary measure. See related file.
Recall
|
Medicines
|
17/10/2010
Ebewe/Santoz has initiated a voluntary recall of certain lots of 5-fluorouracil as a precautionary measure. See related file.
Medicines
|
28/09/2010
Notice of supply difficulties for PegIntron Powder and Solvent for Solution for Injection. See related file.
Recall
|
Medicines
|
29/09/2008
The following quality defect has been identified in the drug product Ionsys (Fentanyl) 40 microgram per dose iontophoretic transdermal system: A defect in the IONSYS systems may potentially cause the system to self-activate. See related files.
Replacement
|
Medicines
|
18/08/2008
Exchange of unbuffered and weakly buffered infusion solutions. See associated files.
Medicines
|
18/01/2008
Communication from the Federal Office for Safety in Health Care on Gardasil. You related file.
Recall
|
Medicines
|
06/11/2007
Information on the suspension of marketing of parenterally administrable drug products containing aprotinin. See related files.
Recall
|
Medicines
|
31/08/2007
Information on market withdrawal of Clobutinol-containing drugs (Silomat®) up to and including patient level. See related files.